Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy

EMBO Journal

Volumn 20, Issue 11, 2001, Pages 2757-2767

  Nicol, Rebekka L ^a   Frey, Norbert ^a   Pearson, Gray ^b   Cobb, Melanie ^b   Richardson, James ^a   Olson, Eric N ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Dilated cardiomyopathy; Heart; Leukemia inhibitory factor; Mitogen activated protein kinase

Indexed keywords

LEUKEMIA INHIBITORY FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE MEK5; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DISEASE ASSOCIATION; ENZYME ACTIVATION; GENE EXPRESSION; HEART DILATATION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SARCOMERE; SIGNAL TRANSDUCTION; SUDDEN DEATH; TRANSGENIC MOUSE;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; CARDIOMYOPATHY, DILATED; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; ENZYME ACTIVATION; GROWTH INHIBITORS; HEART; HEART VENTRICLES; HUMANS; INTERLEUKIN-6; LEUKEMIA INHIBITORY FACTOR; LYMPHOKINES; MAP KINASE KINASE 5; MICE; MICE, TRANSGENIC; MITOGEN-ACTIVATED PROTEIN KINASE 7; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCARDIUM; RATS; RECOMBINANT PROTEINS; SARCOMERES; SEQUENCE DELETION; TRANSFECTION;

EID: 0035355360     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/20.11.2757     Document Type: Article

References (41)

1. Big mitogen-activated protein kinase 1 (BMK1) is a redox-sensitive kinase
2. Role of mitogen-activated protein kinases in ischemia and reperfusion injury: The good and the bad
3. Enhanced Gαq signaling: A common pathway mediates cardiac hypertrophy and apoptotic heart failure
4. Use of recombinant adenovirus for metabolic engineering of mammalian cells
5. The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice
6. The dual-specificity phosphatase MKP-1 limits the cardiac hypertrophic response in vitro and in vivo
7. Stress pathways and heart failure
8. Isolation of MEK5 and differential expression of alternatively spliced forms
9. New insights into the control of MAP kinase pathways
10. Contribution of the ERK5/MEK5 pathway to Ras/Raf signaling and growth control
11. Dilated cardiomyopathy in transgenic mice expressing a dominant-negative CREB transcription factor in the heart
12. Decoding calcium signals involved in cardiac growth and function
13. Signaling from G protein-coupled receptors to ERK5/Big MAPK 1 involves Gαq and Gα12/13 families of heterotrimeric G proteins. Evidence for the existence of a novel Ras and Rho-independent pathway
14. Isolation and characterization of the mouse cardiac myosin heavy chain genes
15. Models of dilated cardiomyopathy in the mouse and the hamster
16. Ablation of the murine α myosin heavy chain gene leads to dosage effects and functional deficits in the heart
17. Activation of the protein kinase ERK5/BMK1 by receptor tyrosine kinases. Identification and characterization of a signaling pathway to the nucleus
18. ERK5 is a novel type of mitogen-activated protein kinase containing a transcriptional activation domain
19. Calmodulin kinases II and IV and calcineurin are involved in leukemia inhibitory factor-induced cardiac hypertrophy in rats
20. BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C
21. Nerve growth factor induces survival and differentiation through two distinct signaling cascades in PC12 cells
22. Significance of ERK cascade compared with JAK/STAT and PI3-K pathway in gp130-mediated cardiac hypertrophy
23. Activation of JAK-STAT and MAP kinases by leukemia inhibitory factor through gp130 in cardiac myocytes
24. Primary structure of BMK1: A new mammalian map kinase
25. Death by design. Programmed cell death in cardiovascular biology and disease
26. Genetic dissection of cardiac growth control pathways
27. The absence of desmin leads to cardiomyocyte hypertrophy and cardiac dilation with compromised systolic function
28. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy
29. From the sarcomere to the nucleus: Role of genetics and signaling in structural heart disease
30. Activation of phosphatidylinositol 3-kinase through glycoprotein 130 induces protein kinase B and p70 S6 kinase phosphorylation in cardiac myocytes
31. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo
32. Mechanical stress-induced cardiac hypertrophy: Mechanisms and signal transduction pathways
33. Cellular mechanisms of cardiac hypertrophy
34. Differential regulation of p90 ribosomal S6 kinase and big mitogen-activated protein kinase 1 by ischemia/reperfusion and oxidative stress in perfused guinea pig hearts
35. Correlation of myocyte lengthening to chamber dilation in the spontaneously hypertensive heart failure (SHHF) rat
36. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family
37. 2-terminal kinase in ventricular muscle cells
38. Cardiotrophin-1 and the role of gp130-dependent signaling pathways in cardiac growth and development
39. Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy. Assembly of sarcomeric units in series via gp130/leukemia inhibitory factor receptor-dependent pathways
40. TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice
41. Components of a new human protein kinase signal transduction pathway